Muscle metabolic alterations assessed by 31-phosphorus magnetic resonance spectroscopy in mild becker muscular dystrophy

Muscle and Nerve

Volumn 44, Issue 5, 2011, Pages 816-818

  Tosetti, Michela ^a   Linsalata, Stefania ^a   Battini, Roberta ^a   Volpi, Leda ^b   Cini, Claudio ^d   Presciutti, Otello ^c   Muntoni, Francesco ^e   Cioni, Giovanni ^a,b   Siciliano, Gabriele ^b  

^a DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

31 phosphorus magnetic resonance spectroscopy; Becker muscular dystrophy; Exercising muscle; Muscular energy metabolism; Phosphocreatine

Indexed keywords

ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; HUMAN; MUSCLE BIOPSY; MUSCLE CONTRACTION; MUSCLE METABOLISM; MUSCULAR DYSTROPHY; NUCLEAR MAGNETIC RESONANCE SCANNER; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 80054874520     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22181     Document Type: Article

References (24)

1. Arnold DL, Matthews PM, Radda GK. Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR. Magn Reson Med 1984;1: 307-315.
2. Taylor DJ, Bore PJ, Styles P, Gadian DG, Radda GK. Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. Mol Biol Med 1983;1:77-94.
3. Barany M, Siegel IM, Venkatasubramanian PN, Mok E, Wilbur AC. Human leg neuromuscular diseases: P-31 MR spectroscopy. Radiology 1989;172:503-508.
4. Barbiroli B, Funicello R, Iotti S, Montagna P, Ferlini A, Zaniol P. 31P-NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/BMD carriers. Altered rate of phosphate transport. J Neurol Sci 1992;109:188-195.
5. Kemp GJ, Taylor DJ, Dunn JF, Frostick SP, Radda GK. Cellular energetics of dystrophic muscle. J Neurol Sci 1993;116:201-206.
6. Lodi R, Kemp GJ, Muntoni F, Thompson CH, Rae C, Taylor J, et al. Reduced cytosolic acidification during exercise suggests defective glycolytic activity in skeletal muscle of patients with Becker muscular dystrophy. An in vivo 31P magnetic resonance spectroscopy study. Brain 1999;122:121-130.
7. Newman RJ, Bore PJ, Chan L, Gadian DG, Styles P, Taylor D, et al. Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy. Br Med J (Clin Res Ed) 1982;284:1072-1074.
8. Younkin DP, Berman P, Sladky J, Chee C, Bank W, Chance B. 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology 1987;37:165-169.
9. Lodi R, Muntoni F, Taylor J, Kumar S, Sewry CA, Blamire A, et al. Correlative MR imaging and 31P-MR spectroscopy study in sarcoglycan deficient limb girdle muscular dystrophy. Neuromuscul Disord 1997;7:505-511.
10. Vignos PJ, Archibald KC. Maintenance of ambulation in childhood muscular dystrophy. J Chronic Dis 1960;12:273-290.
11. Zaniol P, Serafini M, Ferraresi M, Golinelli R, Bassoli P, Canossi I, et al. Muscle 31P-MR spectroscopy performed routinely in a clinical environment by a whole-body imager/spectrometer. Phys Med 1992; 8:87-91.
12. Fowler MD, Ryschon TW, Wysong RE, Combs CA, Balaban RS. Normalized metabolic stress for 31P-MR spectroscopy studies of human skeletal muscle: MVC vs. muscle volume. J Appl Physiol 1997;83: 875-883.
13. Newcomer BR, Boska MD. Adenosine triphosphate production rates, metabolic economy calculations, pH, phosphomonoesters, phosphodiesters, and force output during short-duration maximal isometric plantar flexion exercises and repeated maximal isometric plantar flexion exercises. Muscle Nerve 1997;20:336-346.
14. Mattei JP, Kozak-Ribbens G, Roussel M, Le Fur Y, Cozzone PJ, Bendahan D. New parameters reducing the interindividual variability of metabolic changes during muscle contraction in humans. A (31) P MRS study with physiological and clinical implications. Biochim Biophys Acta 2002;1554:129-136.
15. Lim KO, Pauly J, Webb P, Hurd R, Macovski A. Short TE phosphorus spectroscopy using a spin-echo pulse. Magn Reson Med 1994;32:98-103.
16. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, et al. Java-based graphical user interface for the MRUI quantitation package. Magn Reson Mater Phys 2001;12:141-152.
17. Vanhamme L, van den Boogaart A, van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35-3.
18. Kemp GJ, Thompson CH, Taylor DJ, Radda GK. Proton efflux in human skeletal muscle during recovery from exercise. Eur J Appl Physiol 1997;76:462-471.
19. Roussel M, Bendahan D, Mattei JP, Le Fur Y, Cozzone PJ. 31P magnetic resonance spectroscopy study of phosphocreatine recovery kinetics in skeletal muscle: the issue of intersubject variability. Biochim Biophys Acta 2000;1457:18-26.
20. Argov Z, Löfberg M, Arnold D. Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy. Muscle Nerve 2000;23:1316-1334.
21. Juel C. Muscle pH regulation: role of training. Acta Physiol Scand 1998;162:359-366.
22. Crosbie RH. NO vascular control in Duchenne muscular dystrophy. Nat Med 2001;7:27-29.
23. Sander M, Chavoshan B, Harris SA, Iannoccone SM, Stull JT, Thomas GD, et al. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci USA 2000;97: 13818-13823.
24. Wells KE, Torelli S, Lu Q, Brown SC, Partridge T, Muntoni F, et al. Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle. Neuromuscul Disord 2003;13:21-31.